Contact your GP if you experience: Persistent insomnia lasting more than three months despite implementing sleep hygiene measures, or sooner if it severely affects your daily functioning Severe sleep deprivation that impairs your ability to function safely during daytime activities, particularly if operating machinery or driving Mood changes accompanying sleep disturbance, including persistent low mood, anxiety, or irritability that may indicate depression Impact on quality of life , including inability to work, maintain relationships, or engage in usual activities Seek urgent medical attention if you experience: Chest pain or palpitations during sleep (call 999) Severe breathing difficulties during sleep (call 999) Thoughts of self-harm or suicide (contact your GP urgently, call NHS 111, or 999 in an emergency) Your healthcare provider may conduct a thorough assessment to determine whether the sleep disturbance is related to Wegovy, an underlying condition, or other factors

Recently, a large study identified a higher rate of acne in women using GLP-1 medications compared to those who werent
GLP-1 therapy pairs effectively with our BHRT program, peptide therapy, health optimization programs, and diabetes treatment protocols
rather, they may cause or worsen bloating as a gastrointestinal side effect due to delayed gastric emptying
Those with a personal or family history of thyroid cancer, especially medullary thyroid carcinoma, should steer clear of this medication
Additionally, maintaining sterile conditions during peptide preparation and injection is crucial to prevent infections